The US Oncology Network | Strategic Alliance Partners

February 26, 2018

Number One Rankings in 10 Key Performance Areas Reinforce McKesson Specialty Health’s Leading Position in the Oncology and Hematology Market

January 26, 2018

McKesson’s total solution streamlines MIPS reporting and provides access to custom quality measures, optimizing MIPS performance for community-based oncology practices

January 24, 2018

Consultants in Medical Oncology and Hematology (CMOH) has joined The US Oncology Network (The Network).

January 08, 2018

Providers using iKnowMed certified EHR technology are eligible for Quality Performance bonus points under Merit-based Incentive Payment System.

October 09, 2017

Southern Cancer Center, a premier oncology clinic in Alabama and a practice in The US Oncology Network, is the first site in the world to open enrollment for a new clinical trial for newly diagnosed kidney cancer patients.

June 23, 2017

Expanded agreement enhances Value Pathways, providing physicians access to the most recent evidence available for five additional disease states.

March 24, 2017

Practice with largest infusion treatment center in Delaware gains access to world-class treatments and enhances its cutting-edge research program.

February 06, 2017

Joyce A. O’Shaughnessy, MD, addresses the key issues in breast cancer discussed at the 2017 OncLive® State of the Science Summit on Treatment of Metastatic Breast Cancer and shared her expert insight on where triple-negative breast cancer treatment is headed based on recent findings.

January 04, 2017

Kathryn Kolibaba, MD, co-chair, Hematology Research Committee, US Oncology Research, discusses why the Syk inhibitor entospletinib demonstrates efficacy in patients with mantle cell lymphoma (MCL).

December 25, 2016

Keeping a medical practice strong and independent in today’s turbulent environment can be quite challenging.

December 23, 2016

Kathryn Kolibaba, MD, co-chair, Hematology Research Committee, US Oncology Research, discusses the mechanism of action with entospletinib (GS-9973) and its potential as a treatment for patients with mantle cell lymphoma (MCL).

February 26, 2016

New program automates and simplifies processes needed to successfully participate in the Oncology Care Model.

February 17, 2016

Christopher A. Yasenchak, MD, associate chair of Hematology Research, Willamette Valley Cancer Institute and Research Center/US Oncology Research, discusses results of a study examining the addition of brentuximab vedotin to R-CHOP for the treatment of patients with diffuse large B-cell lymphoma.

February 07, 2016

Pathways are effective tools for reducing unnecessary variability in care, a key factor in achieving better outcomes and more predictable costs.

January 21, 2016

Kathryn Kolibaba, MD, discusses the significance of the PYRAMID and other studies, and how she hopes the treatment paradigm for diffuse large b-cell lymphoma will evolve in the future.

December 23, 2015

One of the most widely talked about trends in healthcare is precision medicine, which uses detailed genetic information about a patient’s cancer to more precisely treat the disease, effectively targeting the tumor. This heightened awareness raises an important question: are precision medicine and pathways compatible?

October 06, 2015

Collaboration to share the latest news from The US Oncology Network, a physician-led organization uniting top oncology practices across the nation to deliver high-quality, evidence-based cancer care

September 21, 2015

Debra Patt, MD, physician, Texas Oncology, discusses the current healthcare reform changes and what effects they will have on oncology care.

August 27, 2015

Joyce A. O'Shaughnessy, MD, Texas Oncology-Baylor Charles A. Sammons Cancer Center, discusses new developments in molecular profiling in patients with metastatic breast cancer.

August 21, 2015

Joyce A. O'Shaughnessy, MD, Texas Oncology-Baylor Charles A. Sammons Cancer Center, discusses how the results of phosphoprotein assays can impact treatment decisions for select patients with advanced breast cancer.